Endpoints News – Biotech and pharma business news, with a focus …
Biotech and pharma business news, with a focus on the science, people and money that drive the industry.
News – Endpoints News
News – Endpoints News. Novo Nordisk files 18 lawsuits against GLP-1 compounders in 44 days. 5 hours ago. Pharma. Law. Novartis used a PRV to speed Kisqali's latest indication ...
About Endpoints News – Endpoints News
John D. Carroll is a biotech analyst and writer with decades of prize-winning experience in journalism. A co-founder of Endpoints News, he has covered biopharma for the past 20 years. Aside from ...
Agenda: Endpoints at #JPM24
Top predictions for biotech in 2024. Catalent CEO Alessandro Maselli will be back at the big JPM healthcare confab to talk with Endpoints News founder John Carroll about their top predictions of what’s coming up for the biotech industry in 2024. The stakes couldn’t be higher as the industry grapples with headwinds and new opportunities in a ...
Endpoints Careers - Find your next biopharma job
Endpoints Careers is where biopharma career seekers and employers connect. All jobs have been curated by Endpoints or posted by employers directly to ensure the highest quality. Free basic job postings for companies seeking talent. Find your career today! High quality job postings for business and science leaders in biopharma.
Endpoints at #BIO23: The dawn of a new biotech era
The dawn of a new biotech era. The biotech industry’s annual trade conference is back in Boston. We assess where we are as an industry and break down the future trends in biopharma. Featuring conversations on dealmaking, pipeline trends, biotech funding, and more — plus a focus on what the mid-year outlook holds. Register to watch.
Astellas CEO talks future beyond Xtandi as Japanese drugmaker …
Sep 6, 2024 · Astellas CEO talks future beyond Xtandi as Japanese drugmaker puts roots in Boston. Ryan Cross. Senior Science Correspondent. CAMBRIDGE, MA — When looking to the future of ...
Big dreams dominate among next-gen biotech players
Sep 22, 2024 · Here’s John Carroll’s top picks for the next-gen players of 2022 most likely to make their mark — or go down fighting for a landmark change. This marks Carroll’s 20th year selecting top private biotechs for special recognition. Join us at this special event in Boston to recognize this year’s group. sponsored by. see the winners.
Endpoints at #JPM22 - A look at what's to come in 2022
Endpoints has been there to chronicle it with wall-to-wall coverage, and our founder and editor John Carroll has convened top newsmakers to provide detailed insights about their strategies. For #JPM22, Endpoints is expanding on our proud tradition with multiple panels addressing the most important issues in biopharma R&D. title sponsor.
Endpoints at #JPM24 | Primed to unlock biopharma's next …
The Endpoints Hub will be open for coworking & networking — power up your devices, check email and grab coffee and a bite between session. On Tuesday, you’ll go to biotech downturn survival school, hear about the data private investors expect to see in a tricky capital market and find out the future plans for pharma from top execs in the ...